1. Home
  2. KYMR vs GLBE Comparison

KYMR vs GLBE Comparison

Compare KYMR & GLBE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kymera Therapeutics Inc.

KYMR

Kymera Therapeutics Inc.

HOLD

Current Price

$72.35

Market Cap

6.4B

Sector

Health Care

ML Signal

HOLD

Logo Global-E Online Ltd.

GLBE

Global-E Online Ltd.

HOLD

Current Price

$36.53

Market Cap

6.3B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
KYMR
GLBE
Founded
2015
2013
Country
United States
Israel
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
6.4B
6.3B
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
KYMR
GLBE
Price
$72.35
$36.53
Analyst Decision
Strong Buy
Buy
Analyst Count
24
13
Target Price
$105.96
$49.46
AVG Volume (30 Days)
740.7K
994.4K
Earning Date
02-26-2026
02-18-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.04
Revenue
$43,735,000.00
$888,450,000.00
Revenue This Year
$18.71
$29.22
Revenue Next Year
N/A
$24.19
P/E Ratio
N/A
$846.66
Revenue Growth
N/A
31.57
52 Week Low
$19.45
$26.64
52 Week High
$103.00
$63.69

Technical Indicators

Market Signals
Indicator
KYMR
GLBE
Relative Strength Index (RSI) 47.75 40.05
Support Level $70.00 $36.13
Resistance Level $72.86 $39.00
Average True Range (ATR) 3.44 1.37
MACD 0.04 -0.19
Stochastic Oscillator 57.69 13.58

Price Performance

Historical Comparison
KYMR
GLBE

About KYMR Kymera Therapeutics Inc.

Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of, differentiated medicines that address health problems and that meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.

About GLBE Global-E Online Ltd.

Global E Online Ltd provides e-commerce solutions. The company offers a platform to enable and accelerate direct-to-consumer cross-border e-commerce. The platform was purpose-built for international shoppers to buy seamlessly online and for merchants to sell from and anywhere in the world. The company localizes the shopper experience to make international transactions as seamless as domestic ones. The platform increases the conversion of international traffic into sales by removing much of the complexity associated with international e-commerce. The company derives maximum revenue from the United States.

Share on Social Networks: